Mixed connective tissue disease secondary prevention: Difference between revisions
(Created page with "__NOTOC__ {{Mixed connective tissue disease}} {{CMG}}; {{AE}} {{SHH}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effe...") |
(No difference)
|
Revision as of 13:40, 11 April 2018
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mixed connective tissue disease secondary prevention On the Web |
American Roentgen Ray Society Images of Mixed connective tissue disease secondary prevention |
Mixed connective tissue disease secondary prevention in the news |
Blogs onMixed connective tissue disease secondary prevention |
Directions to Hospitals Treating Mixed connective tissue disease |
Risk calculators and risk factors for Mixed connective tissue disease secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- There are no established measures for the secondary prevention of [disease name].
OR
- Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]